CytoCore® Signs Agreement With Amsino International Granting Worldwide Distribution Rights

Press Release Source: CytoCore, Inc. CytoCore Signs Agreement With Amsino International Granting Worldwide Distribution Rights Thursday April 16, 2009, 6:30 am EDT CHICAGO--()--CytoCore®, Inc. (OTCBB:CYOE), the developer of cost-effective products used for the detection of cancerous and precancerous conditions, recently announced that it has reached an agreement with Amsino International, designating it as the company’s partner for worldwide sales. Under the agreement, Amsino will direct worldwide sales of CytoC
Read article...

CytoCore® Signs Agreement With Amsino International Granting Worldwide Distribution Rights

Press Release Source: CytoCore, Inc. CytoCore Signs Agreement With Amsino International Granting Worldwide Distribution Rights Thursday April 16, 2009, 6:30 am EDT CHICAGO--()--CytoCore®, Inc. (OTCBB:CYOE), the developer of cost-effective products used for the detection of cancerous and precancerous conditions, recently announced that it has reached an agreement with Amsino International, designating it as the company’s partner for worldwide sales. Under the agreement, Amsino will direct worldwide sales of CytoC
Read article...

CytoCore Signs Agreement to Sell Synermed's General Cytology Preservative with SoftPAP

(OTCBB:CYOE) CytoCore, Inc. Press ReleaseSource: CytoCore Inc. CytoCore Signs Agreement to Sell Synermed's General Cytology Preservative with SoftPAPMonday February 23, 6:30 am ET CHICAGO-CytoCore, Inc. , the developer of cost-effective products used for the detection of cancerous and precancerous conditions and privately held Synermed Select Partners, Inc., the provider of clinical laboratory products and services recently announced a distribution agreement that gives CytoCore US and international rights to distribute the Synermed General Cytology Preservative in combination with its SoftPAP® cervical cell collection device. Robert McCullough, Jr., Chief Executive Officer of CytoCore, commented, ?This agreement with
Read article...

CytoCore Signs Agreement to Sell Synermed's General Cytology Preservative with SoftPAP

(OTCBB:CYOE) CytoCore, Inc. Press ReleaseSource: CytoCore Inc. CytoCore Signs Agreement to Sell Synermed's General Cytology Preservative with SoftPAPMonday February 23, 6:30 am ET CHICAGO-CytoCore, Inc. , the developer of cost-effective products used for the detection of cancerous and precancerous conditions and privately held Synermed Select Partners, Inc., the provider of clinical laboratory products and services recently announced a distribution agreement that gives CytoCore US and international rights to distribute the Synermed General Cytology Preservative in combination with its SoftPAP® cervical cell collection device. Robert McCullough, Jr., Chief Executive Officer of CytoCore, commented,
Read article...

CORRECTING and REPLACING CytoCore and Zycom to Sign Distribution Agreement

(OTCBB:CYOE) CytoCore, Inc. Press ReleaseSource: CytoCore, Inc. CORRECTING and REPLACING CytoCore and Zycom to Sign Distribution AgreementTuesday January 20, 11:52 am ET CHICAGO & TEMECULA, Calif.-First graph, first sentence of release should read: CytoCore, Inc. ). The corrected release reads: CYTOCORE AND ZYCOM TO SIGN DISTRIBUTION AGREEMENTCytoCore, Inc. , the developer of cost effective products used for the detection of cancerous and precancerous conditions and privately held Zycom Touch, LLC., recently announced that they have reached an agreement in principle for CytoCore to distribute OmniDROP? on an exclusive basis to medical laboratories, hospitals, and HMO networks in the
Read article...

CytoCore Reports Third Quarter Progress

(OTCBB:CYOE) CytoCore, Inc. Press ReleaseSource: CytoCore Inc. CytoCore Reports Third Quarter ProgressTuesday November 11, 11:39 am ET Pivotal Study of SoftPAP Showed Significant Improvements Over the Spatula/Cytobrush26% Improvement in False Negatives and 33% Improvements in False PositivesRevenue up 87% Year-Over-Year CHICAGO-CytoCore Inc. , the developer of a suite of cost-effective cervical cell collection devices for the early detection of cancer and sexually transmitted diseases, recently reported its continued progress during the third quarter ended September 30, 2008. ?Last month we announced the efficacy and safety results of our 703 patient clinical trial between the SoftPAP® Collector and the conv
Read article...

Pivotal Study of SoftPAP Collector Demonstrates Significant Improvements Over Conventional Collection Technique for PAP Sample

(OTCBB:CYOE) CytoCore, Inc. Press ReleaseSource: CytoCore Inc. Pivotal Study of SoftPAP Collector Demonstrates Significant Improvements Over Conventional Collection Technique for PAP SampleTuesday October 28, 6:30 am ET Significant Improvements Reported Over the Spatula/Cytobrush Across All Study Endpoints26% Percent Improvement in False Negatives; 33% Improvement in False Positives CHICAGO-CytoCore Inc. , the developer of cost-effective, screening systems for early detection of gynecological cancers and sexually transmitted diseases, recently announced the data analysis from its 703 patient clinical trial on Adequacy, Efficacy and Safety between the SoftPAP® Collector compared to the standard Spatula/CytoBrush Technique. Results showed statistically significant improvements versus the Spatula/Cytobr
Read article...

Pivotal Study of SoftPAP Collector Demonstrates Significant Improvements Over Conventional Collection Technique for PAP Sample

(OTCBB:CYOE) CytoCore, Inc. Press ReleaseSource: CytoCore Inc. Pivotal Study of SoftPAP Collector Demonstrates Significant Improvements Over Conventional Collection Technique for PAP SampleTuesday October 28, 6:30 am ET Significant Improvements Reported Over the Spatula/Cytobrush Across All Study Endpoints26% Percent Improvement in False Negatives; 33% Improvement in False Positives CHICAGO-CytoCore Inc. , the developer of cost-effective, screening systems for early detection of gynecological cancers and sexually transmitted diseases, recently announced the data analysis from its 703 patient clinical trial on Adequacy, Efficacy and Safety between the SoftPAP® Collector compared to the standard Spatula/CytoBrush Technique. Results showed statistically significant improvements versus the Spatula/Cytobr
Read article...